Odyssey Therapeutics, Inc. (ODTX) investor relations documents from the company's IR site: 7 press releases. Read in-app with summaries. First-party data.
| Published | Type | Document |
|---|---|---|
| 2026-08-04 | Press release | Odyssey Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update |
| 2026-06-17 | Press release | Odyssey Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update |
| 2026-05-07 | Press release | Odyssey Therapeutics Announces Pricing of Upsized Initial Public Offering |
| 2026-03-10 | Press release | Odyssey Therapeutics Appoints H. Martin Seidel, Ph.D., to Scientific Advisory Board |
| 2026-01-21 | Press release | Odyssey Therapeutics Appoints Jolie M. Siegel as Executive Vice President, General Counsel |
| 2023-11-09 | Press release | PDF Version |
| 2021-12-07 | Press release | PDF Version |
ODTX overview · ODTX earnings · ODTX financials · ODTX KPIs · ODTX ownership · ODTX peers · ODTX filings
Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.